- Home
- KNSA vs MTTR Comparison
KNSA vs MTTR Comparison
Compare KNSA & MTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- MTTR
- Stock Information
- Founded
- KNSA 2015
- MTTR 2011
- Country
- KNSA United Kingdom
- MTTR United States
- Employees
- KNSA N/A
- MTTR N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- MTTR Computer Software: Prepackaged Software
- Sector
- KNSA Health Care
- MTTR Technology
- Exchange
- KNSA Nasdaq
- MTTR Nasdaq
- Market Cap
- KNSA 1.7B
- MTTR 1.5B
- IPO Year
- KNSA 2018
- MTTR N/A
- Fundamental
- Price
- KNSA $26.79
- MTTR $4.77
- Analyst Decision
- KNSA Strong Buy
- MTTR Hold
- Analyst Count
- KNSA 5
- MTTR 5
- Target Price
- KNSA $33.60
- MTTR $4.70
- AVG Volume (30 Days)
- KNSA 283.3K
- MTTR 1.5M
- Earning Date
- KNSA 10-29-2024
- MTTR 11-04-2024
- Dividend Yield
- KNSA N/A
- MTTR N/A
- EPS Growth
- KNSA N/A
- MTTR N/A
- EPS
- KNSA N/A
- MTTR N/A
- Revenue
- KNSA $338,930,000.00
- MTTR $162,275,000.00
- Revenue This Year
- KNSA $58.95
- MTTR $11.65
- Revenue Next Year
- KNSA $36.22
- MTTR $13.39
- P/E Ratio
- KNSA N/A
- MTTR N/A
- Revenue Growth
- KNSA 20.69
- MTTR 3.56
- 52 Week Low
- KNSA $14.12
- MTTR $1.73
- 52 Week High
- KNSA $27.92
- MTTR $4.99
- Technical
- Relative Strength Index (RSI)
- KNSA 58.67
- MTTR 65.22
- Support Level
- KNSA $23.33
- MTTR $4.71
- Resistance Level
- KNSA $27.35
- MTTR $4.87
- Average True Range (ATR)
- KNSA 0.89
- MTTR 0.11
- MACD
- KNSA 0.15
- MTTR 0.00
- Stochastic Oscillator
- KNSA 86.07
- MTTR 86.55
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About MTTR Matterport Inc.
Matterport Inc is a spatial data company focused on digitizing and indexing the built world. Its all-in-one 3D data platform enables anyone to turn a space into an accurate and immersive digital twin which can be used to design, build, operate, promote, and understand any space. The Company recognizes revenue from subscription, license, services and sale of products. Majority of the revenue is generated in the form of subscription fees which it receives from the customers for providing them access to Matterport platform.